Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 9—September 2012

Dispatch

Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium

Liesbet Van Heirstraeten, Samuel Coenen, Christine Lammens, Niel Hens, Herman Goossens, and Surbhi Malhotra-KumarComments to Author 
Author affiliations: University of Antwerp, Antwerp, Belgium (L. Van Heirstraeten, S. Coenen, C. Lammens, N. Hens, H. Goossens, S. Malhotra-Kumar); and University of Hasselt, Hasselt, Belgium (N. Hens)

Main Article

Figure 2

Predominant geno-emm-types that accounted for >5% of macrolide-resistant S. pyogenes, Belgium, 1999–2009.

Figure 2. . Predominant geno-emm-types that accounted for >5% of macrolide-resistant Streptococcus pyogenes, Belgium, 1999–2009.

Main Article

TOP